Takuma Iguchi

Takuma Iguchi

Daiichi-Sankyo Co., Ltd - Tokyo / Japan
Others
AD Scientific Index ID: 4461097
person_outline Takuma Iguchi's MOST POPULAR ARTICLES
1-) A novel HER3-targeting antibody–drug conjugate, U3-1402, exhibits potent therapeutic efficacy through the delivery of cytotoxic payload by efficient internalizationY Hashimoto, K Koyama, Y Kamai, K Hirotani, Y Ogitani, A Zembutsu, ...Clinical Cancer Research 25 (23), 7151-7161, 2019832019
2-) En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASHM Kimura, T Iguchi, K Iwasawa, A Dunn, WL Thompson, Y Yoneyama, ...Cell 185 (22), 4216-4232. e16, 2022582022
3-) Ascorbic acid transported by sodium-dependent vitamin C transporter 2 stimulates steroidogenesis in human choriocarcinoma cellsX Wu, T Iguchi, N Itoh, K Okamoto, T Takagi, K Tanaka, T NakanishiEndocrinology 149 (1), 73-83, 2008572008
4-) Wide application of a novel topoisomerase I inhibitor-based drug conjugation technologyY Ogitani, Y Abe, T Iguchi, J Yamaguchi, T Terauchi, M Kitamura, K Goto, ...Bioorganic & medicinal chemistry letters 26 (20), 5069-5072, 2016552016
5-) Hedgehog signaling through GLI1 and GLI2 is required for epithelial–mesenchymal transition in human trophoblastsC Tang, L Mei, L Pan, W Xiong, H Zhu, H Ruan, C Zou, L Tang, T Iguchi, ...Biochimica et Biophysica Acta (BBA)-General Subjects 1850 (7), 1438-1448, 2015552015